Amikacin Therapy in Newborns

Aminoglycosides, including amikacin, are known for their potent activity against bacteria that cause sepsis in newborn foals. Dosage protocols for aminoglycosides have been extensively studied in humans, and conventional dosing at eight- to 12-hour intervals is now giving way to high-dose, once-daily administration. Human studies have shown that amikacin is more effective and less toxic to th

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners